Bile Acid Tethered Docetaxel‐Based Nanomicelles Mitigate Tumor Progression through Epigenetic Changes

Sreekanth, Vedagopuram ; Kar, Animesh ; Kumar, Sandeep ; Pal, Sanjay ; Yadav, Poonam ; Sharma, Yamini ; Komalla, Varsha ; Sharma, Harsh ; Shyam, Radhey ; Sharma, Ravi Datta ; Mukhopadhyay, Arnab ; Sengupta, Sagar ; Dasgupta, Ujjaini ; Bajaj, Avinash (2021) Bile Acid Tethered Docetaxel‐Based Nanomicelles Mitigate Tumor Progression through Epigenetic Changes Angewandte Chemie International Edition, 60 (10). pp. 5394-5399. ISSN 1433-7851

Full text not available from this repository.

Official URL: http://doi.org/10.1002/anie.202015173

Related URL: http://dx.doi.org/10.1002/anie.202015173

Abstract

Phosphocholine derivative of docetaxel-conjugated lithocholic acid can form stable sub-100 nm nanomicelles (DTX-PC NMs). DTX-PC NMs exhibit superior tolerance and pharmacokinetics over FDA-approved formulation. DTX-PC NMs can retard tumor progression in murine models and induce upregulation of tumor suppressor genes. Superior pharmacokinetic profiling in non-human primates makes them an ideal platform for clinical applications.

Item Type:Article
Source:Copyright of this article belongs to John Wiley & Sons, Inc.
ID Code:124401
Deposited On:19 Nov 2021 07:44
Last Modified:19 Nov 2021 07:44

Repository Staff Only: item control page